The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Research Report 2025
Synopsis
There are commercial vaccines available containing either a live modified PRRS virus or a dead PRRS virus, both of which are used to increase the immunity to these strains of the infection. These vaccines are licensed in both breeding or growing pigs.
The global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market was valued at US$ 363 million in 2023 and is anticipated to reach US$ 696.7 million by 2030, witnessing a CAGR of 10.2% during the forecast period 2024-2030.
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines.
Report Scope
The Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CAHIC
Boehringer Ingelheim
MSD Animal Health
Sino Pharm
Ceva
ChengDu Tecbond
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Phibro Animal Health
Tecon
Zoetis
WINSUN
PULILE
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Government Tender
Market Sales
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
There are commercial vaccines available containing either a live modified PRRS virus or a dead PRRS virus, both of which are used to increase the immunity to these strains of the infection. These vaccines are licensed in both breeding or growing pigs.
The global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market was valued at US$ 363 million in 2023 and is anticipated to reach US$ 696.7 million by 2030, witnessing a CAGR of 10.2% during the forecast period 2024-2030.
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines.
Report Scope
The Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CAHIC
Boehringer Ingelheim
MSD Animal Health
Sino Pharm
Ceva
ChengDu Tecbond
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Phibro Animal Health
Tecon
Zoetis
WINSUN
PULILE
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Government Tender
Market Sales
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Overview
1.1 Product Overview and Scope of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines
1.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Type
1.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Application
1.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Value by Application: (2024-2030)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Estimates and Forecasts
1.4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue 2019-2030
1.4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales 2019-2030
1.4.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Competition by Manufacturers
2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Product Type & Application
2.7 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Competitive Situation and Trends
2.7.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Players Market Share by Revenue
2.7.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Retrospective Market Scenario by Region
3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2019-2030
3.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2019-2024
3.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2025-2030
3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2019-2030
3.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2019-2024
3.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2025-2030
3.4 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
3.4.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2019-2030)
3.4.3 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
3.5.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2019-2030)
3.5.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
3.7.1 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2019-2030)
4.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2019-2024)
4.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2025-2030)
4.1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2019-2030)
4.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2019-2024)
4.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2025-2030)
4.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2019-2030)
5.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2019-2024)
5.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2025-2030)
5.1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2019-2030)
5.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2019-2024)
5.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2025-2030)
5.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CAHIC
6.1.1 CAHIC Corporation Information
6.1.2 CAHIC Description and Business Overview
6.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.1.5 CAHIC Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 MSD Animal Health
6.3.1 MSD Animal Health Corporation Information
6.3.2 MSD Animal Health Description and Business Overview
6.3.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.3.5 MSD Animal Health Recent Developments/Updates
6.4 Sino Pharm
6.4.1 Sino Pharm Corporation Information
6.4.2 Sino Pharm Description and Business Overview
6.4.3 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.4.5 Sino Pharm Recent Developments/Updates
6.5 Ceva
6.5.1 Ceva Corporation Information
6.5.2 Ceva Description and Business Overview
6.5.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.5.5 Ceva Recent Developments/Updates
6.6 ChengDu Tecbond
6.6.1 ChengDu Tecbond Corporation Information
6.6.2 ChengDu Tecbond Description and Business Overview
6.6.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.6.5 ChengDu Tecbond Recent Developments/Updates
6.7 Ringpu Biology
6.6.1 Ringpu Biology Corporation Information
6.6.2 Ringpu Biology Description and Business Overview
6.6.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.7.5 Ringpu Biology Recent Developments/Updates
6.8 Qilu Animal
6.8.1 Qilu Animal Corporation Information
6.8.2 Qilu Animal Description and Business Overview
6.8.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.8.5 Qilu Animal Recent Developments/Updates
6.9 DHN
6.9.1 DHN Corporation Information
6.9.2 DHN Description and Business Overview
6.9.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.9.5 DHN Recent Developments/Updates
6.10 CAVAC
6.10.1 CAVAC Corporation Information
6.10.2 CAVAC Description and Business Overview
6.10.3 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.10.5 CAVAC Recent Developments/Updates
6.11 Komipharm
6.11.1 Komipharm Corporation Information
6.11.2 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.11.3 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.11.5 Komipharm Recent Developments/Updates
6.12 Agrovet
6.12.1 Agrovet Corporation Information
6.12.2 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.12.3 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.12.5 Agrovet Recent Developments/Updates
6.13 Bioveta
6.13.1 Bioveta Corporation Information
6.13.2 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.13.3 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.13.5 Bioveta Recent Developments/Updates
6.14 Jinyu Bio-Technology
6.14.1 Jinyu Bio-Technology Corporation Information
6.14.2 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.14.3 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.14.5 Jinyu Bio-Technology Recent Developments/Updates
6.15 Phibro Animal Health
6.15.1 Phibro Animal Health Corporation Information
6.15.2 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.15.3 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.15.5 Phibro Animal Health Recent Developments/Updates
6.16 Tecon
6.16.1 Tecon Corporation Information
6.16.2 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.16.3 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.16.5 Tecon Recent Developments/Updates
6.17 Zoetis
6.17.1 Zoetis Corporation Information
6.17.2 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.17.3 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.17.5 Zoetis Recent Developments/Updates
6.18 WINSUN
6.18.1 WINSUN Corporation Information
6.18.2 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.18.3 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.18.4 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.18.5 WINSUN Recent Developments/Updates
6.19 PULILE
6.19.1 PULILE Corporation Information
6.19.2 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
6.19.3 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.19.4 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
6.19.5 PULILE Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Chain Analysis
7.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Mode & Process
7.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Marketing
7.4.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Channels
7.4.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors
7.5 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers
8 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Dynamics
8.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends
8.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Drivers
8.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Challenges
8.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
